Kehua Bio-Engineering rejects convertible bond price cut

Shanghai Kehua Bio-Engineering decided not to reduce the conversion price of its convertible bonds despite triggering the downward revision clause.

The company will not propose any downward revision for six months until February 22, 2026, even if trigger conditions are met again. After this period, it will re-evaluate according to the bond prospectus.